Enhancing Access to Transcatheter Tricuspid Interventions Amid Disparities

Affiliations

Editorial

Sachin S Goel et al. JACC Adv. 2024.

. 2024 Oct 17;3(11):101341.

doi: 10.1016/j.jacadv.2024.101341. eCollection 2024 Nov.

¹ Department of Cardiovascular Medicine, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.

No abstract available

Keywords: disparities; tricuspid interventions; tricuspid regurgitation.

Conflict of interest statement

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Inequities in Access to Tricuspid Valve Treatments: The Impact of Procedure and Volume Requirements.
Barker CM, Kemp LS, Mancilla M, Mollenkopf S, Gunnarsson C, Ryan M, David G. Barker CM, et al. JACC Adv. 2024 Oct 18;3(11):101342. doi: 10.1016/j.jacadv.2024.101342. eCollection 2024 Nov. JACC Adv. 2024. PMID: 39469608 Free PMC article.

1. Ahmed T., Khan S.U., Lone A.N., et al. Tricuspid regurgitation related mortality in United States, 1999-2019. Curr Probl Cardiol. 2023;48 - PubMed
1. Sorajja P., Whisenant B., Hamid N., et al. Transcatheter repair for patients with tricuspid regurgitation. N Engl J Med. 2023;388:1833–1842. - PubMed
1. Kodali S., Hahn R.T., Makkar R., et al. Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study. Eur Heart J. 2023;44:4862–4873. - PubMed
1. Torres C., Lozier M.R., Davidson C.J., et al. In-hospital outcomes of transcatheter tricuspid valve repair: an analysis from the national inpatient sample. J Soc Cardiovasc Angiogr Interv. 2022;1 - PMC - PubMed
1. Nathan A.S., Reddy K.P., Yang L., et al. Characteristics of clinical trial sites for novel transcatheter mitral and tricuspid valvular therapies. JAMA Cardiol. 2023;8:120–128. - PMC - PubMed